Administration of cisplatin by inhalation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 10, 2005
app pub date -
Mar 18, 2005
filing date -
Mar 18, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Provided is a method for treating a patient having lung cancer. The method includes administering a lipid composition containing cisplatin to the patient's respiratory tract over the course of at least 2 treatment cycles. At least about 15 mg/m.sup.2 of cisplatin is administered in each treatment cycle, and there is no more than 2 weeks between treatment cycles.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully